YD54

Chemical Structure : YD54

加入收藏

货号: PC-24493Not For Human Use, Lab Use Only.

YD54 is potent, selective, and orally bioavailable SMARCA2 degrading PROTAC with DC50 of 1.2 nM (H322 cell ine), Dmax=99.3%, selectively inhibit gowth of SMARCA4 mutant lung cancer cell lines.

规格	价格	库存	数量
25 mg		Get quote
50 mg		Get quote
100 mg		Get quote

获取报价单

* 请选择数量再加入购物车

or Bulk Inquiry

大包装，大折扣！

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

生物&药学活性

YD54 is potent, selective, and orally bioavailable SMARCA2 degrading PROTAC with DC50 of 1.2 nM (H322 cell ine), Dmax=99.3%, selectively inhibit gowth of SMARCA4 mutant lung cancer cell lines.
YD54 degrades SMARCA2 in H1792 cells with DC50 of 8.1 nM at 24 h and 16 nM at 48 h, with a Dmax of 98.9% at 24 h and 99.2% at 48 h.
YD54 potently degrades SMARCA2 in H322, HCC515, H2030, and H2126 cell lines with DC50 of 1 nM, 1.2 nM, 10.3 nM and 1.6 nM respectively while achieving a maximal degradation (Dmax) of 99.3%, 98.9%, 98.6% and 98.9%.
YDR1 induces degradation of SMARCA2 in the classically accepted PROTAC fashion by E3 ligase-target protein-PROTAC ternary complex formation, ubiquitination, and via the proteasome.
YD54 dose-dependently inhibits SMARCA4 mutant cell lines (H1568 and H1693) with average cellular IC50 of 78 nM respectively in clonogenic assays, with minimal impact on the growth of SMARCA4 WT cell lines.
YD54 (5 mg/kg, once daily by oral gavage for 19 days) inhibits tumor growth with a tumor growth inhibition (TGI) of 62.5, 48.8, and 93.4% in H2023, HCC515, and H2030 xenografts, respectively。
YD54 synergizes with sotorasib to inhibit growth of sotorasib-resistant KRASG12and SMARCA4 comutant cancer cells.

物理化学性质&存储条件

分子量	763.83
分子式	C40H42FN9O6
外观性状	Solid
CAS No.
储存条件	固体粉末 -20°C 12 个月; 4°C 6 个月	配置液 -80°C 6 个月; -20°C 6 个月
Shipping
Solubility	10 mM in DMSO
Chemical Name/SMILES	4-(2-(4-(4-((4-(3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl)piperazin-1-yl)methyl)-2-fluorophenyl)piperazin-1-yl)ethoxy)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione

参考文献

1. Kotagiri S, et al. J Med Chem. 2025 Apr 25. doi: 10.1021/acs.jmedchem.4c02577.

YD54

生物&药学活性

物理化学性质&存储条件

参考文献

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

询单

YD54

生物&药学活性

物理化学性质&存储条件

参考文献

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

询单

Get Quotation Now

* Indicates a Required FieldYour information is safe with us.